Hjem › Amyloidose › California
Kliniske studier for Amyloidose i California
8 studier for Amyloidose søker deltakere på steder i California.
Byer i California
Offisiell studietekst (engelsk)
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
- City of Hope, Duarte
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
- University of California San Francisco, San Francisco
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05652335Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, La Jolla
- Research Site, Los Angeles
- Research Site, San Francisco
- og 1 flere
RekruttererObservasjonsstudie
Alder 18 til 130 · Alle kjønn · Oppdatert 23. sep. 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, La Jolla
- Clinical Trial Site, Laguna Hills
- Clinical Trial Site, Stanford
RekruttererFase 3
Alder 18 til 85 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07052903DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, Beverly Hills
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07358078ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, La Jolla
- Clinical Trial Site, Los Angeles
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT04561518Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- University of California, San Diego (UCSD) - Medical Center, La Jolla
- University of California, Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles
- University of California, San Francisco (UCSF), San Francisco
- og 1 flere
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06563895A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, San Francisco
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. jul. 2026 · NCT07081646MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Cedars-Sinai Medical Center, Los Angeles
- Western Greater Los Angeles VA Medical Center, Los Angeles
- Stanford University, Palo Alto
- og 1 flere
RekruttererFase 3
Alder 18 til 90 · Alle kjønn · Oppdatert 27. mar. 2026 · NCT06128629Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.